MST2 phosphorylation at serine 385 in mitosis inhibits its tumor suppressing activity.

Mammalian sterile 20-like kinase 1/2 (MST1/2) are core tumor suppressors in the Hippo signaling pathway. MST1/2 have been shown to regulate mitotic progression. Here, we report a novel mechanism for phospho-regulation of MST2 in mitosis and its biological significance in cancer. We found that the mitotic kinase cyclin-dependent kinase 1 ...
(CDK1) phosphorylates MST2 in vitro and in vivo at serine 385 during antimitotic drug-induced G2/M phase arrest. This phosphorylation occurs transiently during unperturbed mitosis. Mitotic phosphorylation of MST2 does not affect its kinase activity or Hippo-YAP signaling. We further showed that mitotic phosphorylation-deficient mutant MST2-S385A possesses higher activity in suppressing cell proliferation and anchorage-independent growth in vitro and tumorigenesis in vivo. Together, our findings reveal a novel layer of regulation for MST2 in mitosis and its role in tumorigenesis.
Mesh Terms:
Animals, Antimitotic Agents, CDC2 Protein Kinase, Carcinogenesis, Cell Cycle Checkpoints, Cell Proliferation, Cyclin B, HEK293 Cells, HeLa Cells, Humans, Male, Mice, Nude, Mitosis, Mutant Proteins, Phosphorylation, Phosphoserine, Protein-Serine-Threonine Kinases, Signal Transduction, Tumor Suppressor Proteins
Cell. Signal.
Date: Dec. 01, 2015
Download Curated Data For This Publication
207462
Switch View:
  • Interactions 2